Preliminary Results Presentation for the year ended 31 March 2020
To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.
A recording of the webcast can be accessed via the following link:
Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’
2017 AGM Trading Update – Shareholder Presentation
September 2017: Please click here to see the slides accompanying the AGM Trading Update presentation.
CEO Presents at Cell & Gene Investor Day, April 2017, Boston
Positive results in Phase II stroke trial & Interim results 2016 webcast
Please click on link below for the webcast of the Phase II stroke trial & Interim results presentation :
CFO Michael Hunt Presents at Shares Magazine Investor Evening – 27th October 2016
CEO Presents at the 6th Annual Cell & Gene Partnering Forum on the Mesa 2016
CEO Presents at Cell & Gene Therapy Investor Day March 2016
CFO Michael Hunt puts the investment case forwards for ReNeuron
CEO presents at the 2015 Stem Cell Meeting on the MESA